Takhzyro
Payments companies reported to CMS as associated with Takhzyro. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Takhzyro, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Takhzyro
These are the largest totals companies reported as associated with Takhzyro. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Kaufman | Shreveport, LA | Allergy & Immunology | $105,631.16 |
| Autumn Burnette | Washington, DC | Allergy & Immunology (Internal Medicine) | $93,575.38 |
| William Lumry | Dallas, TX | $87,024.48 | |
| Corinna Bowser | Narberth, PA | Allergy & Immunology | $63,613.23 |
| Cristina Ramos | San Juan, PR | Allergy & Immunology | $58,430.91 |
| Theodore Kelbel | Grand Rapids, MI | Allergy & Immunology | $48,253.51 |
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $42,014.03 |
| Daniel Soteres | Colorado Springs, CO | Allergy | $41,655.00 |
| Joshua Jacobs | Walnut Creek, CA | Allergy | $41,569.70 |
| Marc Riedl | San Diego, CA | Allergy & Immunology | $41,562.15 |
Prescribed Takhzyro?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.